Appendix DExcluded Studies After Full-Text Screening

Publication Details

1.
Takagi H, Manabe H, Umemoto T. Drug-eluting versus bare metal stents for saphenous vein graft intervention. Am J Cardiol. 2010;106:1522–1524. (Reject reason: Letter) [PubMed: 21059450]
2.
Antoniucci D. JETSTENT trial results: impact on ST-segment elevation myocardial infarction interventions. J Invasive Cardiol. 2010;22:23B–25B. (Reject reason: Not a systematic review) [PubMed: 20947933]
3.
Van Den Broek KC, Habibovic M, Pedersen SS. Emotional distress in partners of patients with an implantable cardioverter defibrillator: a systematic review and recommendations for future research. Pacing Clin Electrophysiol. 2010;33:1442–1450. (Reject reason: Population not of interest) [PubMed: 20946298]
4.
Campbell JE, Stone PA, Bates MC. Efficacy of embolic protection devices in renal artery stenting. J Cardiovasc Surg (Torino) 2010;51:747–754. (Reject reason: No study search methods or eligibility criteria were reported) [PubMed: 20924334]
5.
Neschis DG, Scalea TM. Endovascular repair of traumatic aortic injuries. Adv Surg. 2010;44:281–292. (Reject reason: Not a systematic review) [PubMed: 20919527]
6.
Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2010;42:842–853. (Reject reason: Topic not of interest) [PubMed: 20886403]
7.
Amarenco P, Labreuche J, Mazighi M. Lessons from carotid endarterectomy and stenting trials. Lancet. 2010;376:1028–1031. (Reject reason: Editorial) [PubMed: 20870079]
8.
Naylor AR. Managing patients with symptomatic coronary and carotid artery disease. Perspect Vasc Surg Endovasc Ther. 2010;22:70–76. (Reject reason: Not a systematic review) [PubMed: 20858607]
9.
Knepper J, Upchurch GR Jr. A review of clinical trials and registries in descending thoracic aortic aneurysms. Semin Vasc Surg. 2010;23:170–175. (Reject reason: Not a systematic review) [PubMed: 20826294]
10.
Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. Regarding “preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair” J Vasc Surg. 2010;52:820–822. (Reject reason: Not a systematic review) [PubMed: 20816327]
11.
Klein-Weigel P. [Spinal cord stimulation - evidence and personal experience]. Zentralbl Chir. 2010;135:359–362. (Reject reason: Not a systematic review) [PubMed: 20806142]
12.
Beattie MJ, Lee MS. Safety and efficacy of drug-eluting stents compared with bare metal stents in ST-elevation myocardial infarction. Rev Cardiovasc Med. 2010;11:57–73. (Reject reason: Not a systematic review) [PubMed: 20700088]
13.
Navarese EP, Buffon A, De LG, De SS. Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis. Am Heart J. 2010;160:e9. (Reject reason: Letter) [PubMed: 20691822]
14.
Beno M, Rumenapf G. [Comparison between hybrid surgical procedure--intraoperative angioplasty and cross-over bypass with aorto-bifemoral bypass in revascularization of iliac arteries]. Rozhl Chir. 2009;88:720–724. (Reject reason: Not a systematic review) [PubMed: 20662436]
15.
Lanjewar C, Jolly S, Mehta SR. Effects of aspiration thrombectomy on mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of the randomized trials. Indian Heart J. 2009;61:335–340. (Reject reason: Intervention not of interest) [PubMed: 20635735]
16.
Vermeulen H, Westerbos SJ, Ubbink DT. Benefit and harm of iodine in wound care: a systematic review. J Hosp Infect. 2010;76:191–199. (Reject reason: Intervention not of interest) [PubMed: 20619933]
17.
Sparreboom M, van SJ, van Zanten BG, et al. The effectiveness of bilateral cochlear implants for severe-to-profound deafness in children: a systematic review. Otol Neurotol. 2010;31:1062–1071. (Reject reason: Topic not of interest) [PubMed: 20601922]
18.
Ellis E III. Discussion. Internal fixation of mandibular angle fractures: a meta-analysis. Plast Reconstr Surg. 2010;125:1761–1762. (Reject reason: Discussion of an included paper) [PubMed: 20517102]
19.
Cevik C, Nugent K, Perez-Verdia A, Fish RD. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a Not a systematic review. Clin Cardiol. 2010;33:254–260. (Reject reason: Not a systematic review) [PubMed: 20513063]
20.
Seidl K, Strauss M, Kleemann T. [ICD therapy as secondary prevention]. Herzschrittmacherther Elektrophysiol. 2010;21:96–101. (Reject reason: Not a systematic review) [PubMed: 20505945]
21.
Dorr R. [Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus]. Herz. 2010;35:182–190. (Reject reason: No study search methods or eligibility criteria were reported) [PubMed: 20467930]
22.
Balzer JO, Thalhammer A, Khan V, Zangos S, Vogl TJ, Lehnert T. Angioplasty of the pelvic and femoral arteries in PAOD: results and review of the literature. Eur J Radiol. 2010;75:48–56. (Reject reason: Not a systematic review) [PubMed: 20451340]
23.
Bellabarba C, Fisher C, Chapman JR, Dettori JR, Norvell DC. Does early fracture fixation of thoracolumbar spine fractures decrease morbidity or mortality? Spine (Phila Pa 1976) 2010;35:S138–S145. (Reject reason: No implantable device used) [PubMed: 20407345]
24.
Fiehler J, Bakke SJ, Clifton A, et al. Plea of the defence-critical comments on the interpretation of EVA3S, SPACE and ICSS. Neuroradiology. 2010;52:601–610. (Reject reason: Not a systematic review) [PubMed: 20440484]
25.
Shi ZS, Loh Y, Walker G, Duckwiler GR. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions. Stroke. 2010;41:1185–1192. (Reject reason: No implantable device used) [PubMed: 20431084]
26.
Carter MJ. Evidence-based medicine: an overview of key concepts. Ostomy Wound Manage. 2010;56:68–85. (Reject reason: Review of concepts) [PubMed: 20424294]
27.
Bizzarri F, Tudisco A, Ricci M, Rose D, Frati G. Different ways to repair the mitral valve with artificial chordae: a systematic review. J Cardiothorac Surg. 2010;5:22. (Reject reason: No study objectives or eligibility criteria were reported) [PMC free article: PMC2873358] [PubMed: 20377866]
28.
Movahed MR. Re.: Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. J Invasive Cardiol. 2010;22:148–149. (Reject reason: Letter) [PubMed: 20197585]
29.
Tamhane UU, Chetcuti S, Hameed I, Grossman PM, Moscucci M, Gurm HS. Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2010;10:10. (Reject reason: Intervention not of interest) [PMC free article: PMC2838805] [PubMed: 20187958]
30.
Pendyala LK, Yin X, Li J, Chen JP, Chronos N, Hou D. The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC Cardiovasc Interv. 2009;2:1169–1177. (Reject reason: Not a systematic review) [PubMed: 20129542]
31.
Mongeon FP, Belisle P, Joseph L, Eisenberg MJ, Rinfret S. Adjunctive thrombectomy for acute myocardial infarction: A bayesian meta-analysis. Circ Cardiovasc Interv. 2010;3:6–16. (Reject reason: Intervention not of interest) [PubMed: 20118149]
32.
Marazziti D, Consoli G. Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother. 2010;11:331–343. (Reject reason: Not a systematic review) [PubMed: 20102301]
33.
Jennings DL, Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis. J Clin Pharmacol. 2010;50:415–421. (Reject reason: Intervention not of interest) [PubMed: 20081227]
34.
Ramsey S, Robertson A, Ablett MJ, Meddings RN, Hollins GW, Little B. Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol. 2010;24:185–189. (Reject reason: Topic not of interest) [PubMed: 20063999]
35.
Knur R. Carotid artery stenting: a systematic review of randomized clinical trials. Vasa. 2009;38:281–291. (Reject reason: Study objectives and search methodology were not reported) [PubMed: 19998249]
36.
Chen SF, El-Bialy A, Matthews R, Clavijo L. Use of drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction. J Invasive Cardiol. 2009;21:E206–E212. (Reject reason: Not a systematic review) [PubMed: 19901420]
37.
Diehm N, Baumgartner I. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:3083–3084. (Reject reason: Letter) [PubMed: 19880846]
38.
Matsumura JS, Lee WA, Mitchell RS, et al. The Society for Vascular Surgery Practice Guidelines: management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg. 2009;50:1155–1158. (Reject reason: Guideline document developed from an included paper) [PubMed: 19878791]
39.
Gorenoi V, Dintsios CM, Schonermark MP, Hagen A. [Intravascular brachytherapy for peripheral arterial occlusive disease: systematic review of medical efficacy and health economic modelling]. Z Evid Fortbild Qual Gesundhwes. 2009;103:331–340. (Reject reason: Intervention not of interest) [PubMed: 19839205]
40.
Ehdaie A, Lee MS. Drug-eluting stents in primary percutaneous coronary intervention for ST-elevation myocardial infarction: an up-to-date review of the literature. Minerva Cardioangiol. 2009;57:645–655. (Reject reason: Not a systematic review) [PubMed: 19838154]
41.
Quenneville SP, Xie X, Brophy JM. The cost-effectiveness of Maze procedures using ablation techniques at the time of mitral valve surgery. Int J Technol Assess Health Care. 2009;25:485–496. (Reject reason: Topic not of interest) [PubMed: 19818194]
42.
Parrish LC, Miyamoto T, Fong N, Mattson JS, Cerutis DR. Non-bioabsorbable vs. bioabsorbable membrane: assessment of their clinical efficacy in guided tissue regeneration technique. A systematic review. J Oral Sci. 2009;51:383–400. (Reject reason: Topic not of interest) [PubMed: 19776505]
43.
Tjardes T, Shafizadeh S, Rixen D, et al. Image-guided spine surgery: state of the art and future directions. Eur Spine J. 2010;19:25–45. (Reject reason: Intervention not of interest) [PMC free article: PMC2899744] [PubMed: 19763640]
44.
Eeckhout E. Thrombectomy in acute ST-elevation myocardial infarction: keep it simple. Eur Heart J. 2009;30:2180–2181. (Reject reason: Intervention not of interest) [PubMed: 19726438]
45.
Burzotta F, De VM, Gu YL, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009;30:2193–2203. (Reject reason: Intervention not of interest) [PubMed: 19726437]
46.
Kingston GT, Darby CR, Roberts IS. The pathology of depopulated bovine ureter xenografts utilized for vascular access in haemodialysis patients. Histopathology. 2009;55:154–160. (Reject reason: Topic not of interest) [PubMed: 19694822]
47.
Byrne RA, Sarafoff N, Kastrati A, Schomig A. Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment. Drug Saf. 2009;32:749–770. (Reject reason: Not a systematic review) [PubMed: 19670915]
48.
Pedersen SS, van den BM, Theuns DA. A viewpoint on the impact of device advisories on patient-centered outcomes. Pacing Clin Electrophysiol. 2009;32:1006–1011. (Reject reason: Not a systematic review) [PubMed: 19659620]
49.
Noordeen MH, Garrido E, Tucker SK, Elsebaie HB. The surgical treatment of congenital kyphosis. Spine (Phila Pa 1976) 2009;34:1808–1814. (Reject reason: Not a systematic review) [PubMed: 19644332]
50.
Hedequist DJ. Instrumentation and fusion for congenital spine deformities. Spine (Phila Pa 1976) 2009;34:1783–1790. (Reject reason: Not a systematic review) [PubMed: 19644329]
51.
Garg S, Serruys P. Drug-eluting stents are safe. Clin Pharmacol Ther. 2009;86:130–132. (Reject reason: Not a systematic review) [PubMed: 19621006]
52.
Nicolaou G. Endovascular treatment of blunt traumatic thoracic aortic injury. Semin Cardiothorac Vasc Anesth. 2009;13:106–112. (Reject reason: Not a systematic review) [PubMed: 19617250]
53.
Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int. 2009;18:70–74. (Reject reason: Not a systematic review) [PubMed: 19585727]
54.
Chung KC, Ghori AK. Discussion. Systematic review of skin graft donor-site dressings. Plast Reconstr Surg. 2009;124:307–308. (Reject reason: A review of systematic reviews) [PubMed: 19568093]
55.
Sears SF, Matchett M, Conti JB. Effective management of ICD patient psychosocial issues and patient critical events. J Cardiovasc Electrophysiol. 2009;20:1297–1304. (Reject reason: Not a systematic review) [PubMed: 19563356]
56.
Ojike NI, Roberts CS, Giannoudis PV. Compartment syndrome of the thigh: a systematic review. Injury. 2010;41:133–136. (Reject reason: Topic not of interest) [PubMed: 19555950]
57.
Karpov I, Samko AN, Buza VV. [Drug-eluting stents: long-term safety]. Ter Arkh. 2009;81:36–41. (Reject reason: Not a systematic review) [PubMed: 19537584]
58.
Ilahi OA, Nolla JM, Ho DM. Intra-tunnel fixation versus extra-tunnel fixation of hamstring anterior cruciate ligament reconstruction: a meta-analysis. J Knee Surg. 2009;22:120–129. (Reject reason: No implantable devices, comparison of autografts) [PubMed: 19476176]
59.
Geissler HJ, Schlensak C, Sudkamp M, Beyersdorf F. Heart valve surgery today: indications, operative technique, and selected aspects of postoperative care in acquired valvular heart disease. Dtsch Arztebl Int. 2009;106:224–233. (Reject reason: Not a systematic review) [PMC free article: PMC2683397] [PubMed: 19471589]
60.
De VM, Burzotta F, Biondi-Zoccai GG, et al. Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data. Vasc Health Risk Manag. 2009;5:243–247. (Reject reason: Intervention not of interest) [PMC free article: PMC2672436] [PubMed: 19436647]
61.
Ertas G, van Beusekom HM, van der Giessen WJ. Late stent thrombosis, endothelialisation and drug-eluting stents. Neth Heart J. 2009;17:177–180. (Reject reason: Not a systematic review) [PMC free article: PMC2669249] [PubMed: 19421365]
62.
Digby GC, Daubney ME, Baggs J, et al. Physiotherapy and cardiac rhythm devices: a review of the current scope of practice. Europace. 2009;11:850–859. (Reject reason: Not a systematic review) [PubMed: 19411677]
63.
Ng VG, Stone GW. Diabetics and drug-eluting stents in ST segment elevation myocardial infarction: confidence in numbers. Rev Esp Cardiol. 2009;62:343–346. (Reject reason: Editorial) [PubMed: 19401117]
64.
Yokochi F. [Deep brain stimulation for Parkinson's disease and dystonia]. Brain Nerve. 2009;61:473–483. (Reject reason: Not a systematic review) [PubMed: 19378817]
65.
Sakhuja R, Keebler M, Lai TS, McLaughlin GC, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol. 2009;103:735–741. (Reject reason: Duplicate retrieval) [PubMed: 19231344]
66.
Oswald H, Klein G, Struber M, Gardiwal A. Implantable defibrillator with left ventricular assist device compatibility. Interact Cardiovasc Thorac Surg. 2009;8:579–580. (Reject reason: Primary study) [PubMed: 19223309]
67.
Mandava P, Kent TA. Percutaneous clot removal in acute ischemic stroke. Arch Neurol. 2009;66:283–284. (Reject reason: Commentary) [PubMed: 19204174]
68.
Naylor AR. Does the risk of post-CABG stroke merit staged or synchronous reconstruction in patients with symptomatic or asymptomatic carotid disease? J Cardiovasc Surg (Torino) 2009;50:71–81. (Reject reason: Not a systematic review) [PubMed: 19179993]
69.
Amin AP, Mamtani MR, Kulkarni H. Factors influencing the benefit of adjunctive devices during percutaneous coronary intervention in ST-segment elevation myocardial infarction: meta-analysis and meta-regression. J Interv Cardiol. 2009;22:49–60. (Reject reason: Intervention not of interest) [PubMed: 19141090]
70.
Takkenberg JJ, Klieverik LM, Schoof PH, et al. The Ross procedure: a systematic review and meta-analysis. Circulation. 2009;119:222–228. (Reject reason: Evaluation of autograft) [PubMed: 19118260]
71.
Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132–140. (Reject reason: Topic not of interest) [PubMed: 19081409]
72.
Sleilaty G, Achouh P, Fabiani JN. [Stenting or coronary artery bypass surgery for triple vessel disease?]. Ann Cardiol Angeiol (Paris) 2009;58:104–112. (Reject reason: Not a systematic review) [PubMed: 18930176]
73.
Patel TR, Bulsara KR. Current strategies for the treatment of intracranial atherosclerotic internal carotid artery stenosis. Neurosurg Rev. 2009;32:23–27. (Reject reason: Narrative review) [PubMed: 18818960]
74.
Hanson MD, Gauld M, Wathen CN, Macmillan HL. Nonpharmacological interventions for acute wound care distress in pediatric patients with burn injury: a systematic review. J Burn Care Res. 2008;29:730–741. (Reject reason: Intervention not of interest) [PubMed: 18695617]
75.
De LG, Cassetti E, Marino P. Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials. J Thromb Thrombolysis. 2009;27:365–378. (Reject reason: Intervention not of interest) [PubMed: 18498003]
76.
Tomaske M, Bauersfeld U. Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease. Pacing Clin Electrophysiol. 2008;31(Suppl 1):S35–S37. (Reject reason: Narrative review) [PubMed: 18226033]
77.
Celik T, Iyisoy A, Yuksel UC, Isik E. Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior. Int J Cardiol. 2009;131:269–270. (Reject reason: Editorial) [PubMed: 17692947]
78.
Bryant J, Brodin H, Loveman E, Payne E, Clegg A. The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review. Health Technol Assess. 2005;9:1–150. iii. (Reject reason: Duplication publication) [PubMed: 16153353]
79.
Pourati I, Hyder M, Rosenthal L. Indications for implantable cardiac defibrillators in patients with congestive heart failure: implications of the sudden cardiac death in heart failure trial. Curr Cardiol Rep. 2005;7:223–228. (Reject reason: Narrative review) [PubMed: 15865865]
80.
Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44:2166–2172. (Reject reason: Met sufficient number of reviews) [PubMed: 15582314]
81.
Seidl K, Strauss M, Kleemann T. [ICD therapy as secondary prevention]. Herzschrittmacherther Elektrophysiol. 2010;21:96–101. (Reject reason: Narrative review) [PubMed: 20505945]